STEDMAN CLINICAL TRIALS Trademark

Trademark Overview


On Tuesday, September 17, 2024, a trademark application was filed for STEDMAN CLINICAL TRIALS with the United States Patent and Trademark Office. The USPTO has given the STEDMAN CLINICAL TRIALS trademark a serial number of 98754175. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, March 18, 2025. The STEDMAN CLINICAL TRIALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
stedman clinical trials

General Information


Serial Number98754175
Word MarkSTEDMAN CLINICAL TRIALS
Filing DateTuesday, September 17, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, March 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 17, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressTampa, FL 33613

Trademark Events


Event DateEvent Description
Tuesday, September 17, 2024APPLICATION FILING RECEIPT MAILED
Tuesday, September 17, 2024NEW APPLICATION ENTERED
Monday, January 27, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 17, 2025ASSIGNED TO EXAMINER
Tuesday, March 18, 2025NON-FINAL ACTION WRITTEN
Tuesday, March 18, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 18, 2025NON-FINAL ACTION E-MAILED